These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 20194601

  • 1. The proline-rich region of pneumococcal surface proteins A and C contains surface-accessible epitopes common to all pneumococci and elicits antibody-mediated protection against sepsis.
    Daniels CC, Coan P, King J, Hale J, Benton KA, Briles DE, Hollingshead SK.
    Infect Immun; 2010 May; 78(5):2163-72. PubMed ID: 20194601
    [Abstract] [Full Text] [Related]

  • 2. The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia.
    Brooks-Walter A, Briles DE, Hollingshead SK.
    Infect Immun; 1999 Dec; 67(12):6533-42. PubMed ID: 10569772
    [Abstract] [Full Text] [Related]

  • 3. Mapping of epitopes recognized by antibodies induced by immunization of mice with PspA and PspC.
    Vadesilho CF, Ferreira DM, Gordon SB, Briles DE, Moreno AT, Oliveira ML, Ho PL, Miyaji EN.
    Clin Vaccine Immunol; 2014 Jul; 21(7):940-8. PubMed ID: 24807052
    [Abstract] [Full Text] [Related]

  • 4. Streptococcus pneumoniae Binds to Host Lactate Dehydrogenase via PspA and PspC To Enhance Virulence.
    Park SS, Gonzalez-Juarbe N, Martínez E, Hale JY, Lin YH, Huffines JT, Kruckow KL, Briles DE, Orihuela CJ.
    mBio; 2021 May 04; 12(3):. PubMed ID: 33947761
    [Abstract] [Full Text] [Related]

  • 5. Regions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection model.
    Roche H, Håkansson A, Hollingshead SK, Briles DE.
    Infect Immun; 2003 Mar 04; 71(3):1033-41. PubMed ID: 12595413
    [Abstract] [Full Text] [Related]

  • 6. The factor H-binding fragment of PspC as a vaccine antigen for the induction of protective humoral immunity against experimental pneumococcal sepsis.
    Ricci S, Janulczyk R, Gerlini A, Braione V, Colomba L, Iannelli F, Chiavolini D, Oggioni MR, Björck L, Pozzi G.
    Vaccine; 2011 Oct 26; 29(46):8241-9. PubMed ID: 21911026
    [Abstract] [Full Text] [Related]

  • 7. The Modified Surface Killing Assay Distinguishes between Protective and Nonprotective Antibodies to PspA.
    Genschmer KR, Vadesilho CFM, McDaniel LS, Park SS, Hale Y, Miyaji EN, Briles DE.
    mSphere; 2019 Dec 11; 4(6):. PubMed ID: 31826968
    [Abstract] [Full Text] [Related]

  • 8. Genetic immunization with the region encoding the alpha-helical domain of PspA elicits protective immunity against Streptococcus pneumoniae.
    Bosarge JR, Watt JM, McDaniel DO, Swiatlo E, McDaniel LS.
    Infect Immun; 2001 Sep 11; 69(9):5456-63. PubMed ID: 11500417
    [Abstract] [Full Text] [Related]

  • 9. Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260.
    McDaniel LS, Ralph BA, McDaniel DO, Briles DE.
    Microb Pathog; 1994 Nov 11; 17(5):323-37. PubMed ID: 7723659
    [Abstract] [Full Text] [Related]

  • 10. Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection.
    Chen A, Mann B, Gao G, Heath R, King J, Maissoneuve J, Alderson M, Tate A, Hollingshead SK, Tweten RK, Briles DE, Tuomanen EI, Paton JC.
    Clin Vaccine Immunol; 2015 Oct 11; 22(10):1079-89. PubMed ID: 26245351
    [Abstract] [Full Text] [Related]

  • 11. Immunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection.
    Moreno AT, Oliveira ML, Ferreira DM, Ho PL, Darrieux M, Leite LC, Ferreira JM, Pimenta FC, Andrade AL, Miyaji EN.
    Clin Vaccine Immunol; 2010 Mar 11; 17(3):439-46. PubMed ID: 20089795
    [Abstract] [Full Text] [Related]

  • 12. A modified surface killing assay (MSKA) as a functional in vitro assay for identifying protective antibodies against pneumococcal surface protein A (PspA).
    Genschmer KR, Accavitti-Loper MA, Briles DE.
    Vaccine; 2013 Dec 17; 32(1):39-47. PubMed ID: 24211169
    [Abstract] [Full Text] [Related]

  • 13. Correlation between in vitro complement deposition and passive mouse protection of anti-pneumococcal surface protein A monoclonal antibodies.
    Khan N, Qadri RA, Sehgal D.
    Clin Vaccine Immunol; 2015 Jan 17; 22(1):99-107. PubMed ID: 25410204
    [Abstract] [Full Text] [Related]

  • 14. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
    Gor DO, Ding X, Briles DE, Jacobs MR, Greenspan NS.
    Infect Immun; 2005 Mar 17; 73(3):1304-12. PubMed ID: 15731027
    [Abstract] [Full Text] [Related]

  • 15. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.
    Cao J, Chen D, Xu W, Chen T, Xu S, Luo J, Zhao Q, Liu B, Wang D, Zhang X, Shan Y, Yin Y.
    Vaccine; 2007 Jun 28; 25(27):4996-5005. PubMed ID: 17524530
    [Abstract] [Full Text] [Related]

  • 16. Prevention of pneumococcal disease in mice immunized with conserved surface-accessible proteins.
    Hamel J, Charland N, Pineau I, Ouellet C, Rioux S, Martin D, Brodeur BR.
    Infect Immun; 2004 May 28; 72(5):2659-70. PubMed ID: 15102774
    [Abstract] [Full Text] [Related]

  • 17. The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection.
    Briles DE, Hollingshead S, Brooks-Walter A, Nabors GS, Ferguson L, Schilling M, Gravenstein S, Braun P, King J, Swift A.
    Vaccine; 2000 Feb 25; 18(16):1707-11. PubMed ID: 10689153
    [Abstract] [Full Text] [Related]

  • 18. PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type.
    McDaniel LS, Sheffield JS, Delucchi P, Briles DE.
    Infect Immun; 1991 Jan 25; 59(1):222-8. PubMed ID: 1987036
    [Abstract] [Full Text] [Related]

  • 19. The genetic background of Streptococcus pneumoniae affects protection in mice immunized with PspA.
    He X, McDaniel LS.
    FEMS Microbiol Lett; 2007 Apr 25; 269(2):189-95. PubMed ID: 17355599
    [Abstract] [Full Text] [Related]

  • 20. Enhanced protective immunity against pneumococcal infection with PspA DNA and protein.
    Moore QC, Bosarge JR, Quin LR, McDaniel LS.
    Vaccine; 2006 Jul 17; 24(29-30):5755-61. PubMed ID: 16759765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.